Kaplan-Meier curves for PFS from the landmark of starting consolidation therapy according to the presence or absence of cytogenetic abnormalities. The figure shows PFS for patients with no cytogenetic abnormality, or with del(13q) positivity but lack of t(4;14) and del(17p), or t(4;14) and/or del(17p) positivity who received VTD consolidation therapy (A) or TD consolidation therapy (B). *P value according to log-rank test.